BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 15326162)

  • 1. Cisplatin stabilizes a multimeric complex of the human Ctr1 copper transporter: requirement for the extracellular methionine-rich clusters.
    Guo Y; Smith K; Petris MJ
    J Biol Chem; 2004 Nov; 279(45):46393-9. PubMed ID: 15326162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter.
    Guo Y; Smith K; Lee J; Thiele DJ; Petris MJ
    J Biol Chem; 2004 Apr; 279(17):17428-33. PubMed ID: 14976198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
    Song IS; Savaraj N; Siddik ZH; Liu P; Wei Y; Wu CJ; Kuo MT
    Mol Cancer Ther; 2004 Dec; 3(12):1543-9. PubMed ID: 15634647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin.
    Liang ZD; Stockton D; Savaraj N; Tien Kuo M
    Mol Pharmacol; 2009 Oct; 76(4):843-53. PubMed ID: 19570948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex.
    Ma G; Wu Q; Wu X; Arnesano F; Natile G; Sletten E; Liu Y
    J Inorg Biochem; 2015 Dec; 153():239-246. PubMed ID: 26235215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivity of platinum-based antitumor drugs towards a Met- and His-rich 20mer peptide corresponding to the N-terminal domain of human copper transporter 1.
    Wu Z; Liu Q; Liang X; Yang X; Wang N; Wang X; Sun H; Lu Y; Guo Z
    J Biol Inorg Chem; 2009 Nov; 14(8):1313-23. PubMed ID: 19669174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between copper and cisplatin transport mediated by human copper transporter 1 (hCTR1).
    Du X; Wang X; Li H; Sun H
    Metallomics; 2012 Jul; 4(7):679-85. PubMed ID: 22552365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper transporters and the cellular pharmacology of the platinum-containing cancer drugs.
    Howell SB; Safaei R; Larson CA; Sailor MJ
    Mol Pharmacol; 2010 Jun; 77(6):887-94. PubMed ID: 20159940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1.
    Petris MJ; Smith K; Lee J; Thiele DJ
    J Biol Chem; 2003 Mar; 278(11):9639-46. PubMed ID: 12501239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the human high-affinity copper transporter in copper homeostasis regulation and cisplatin sensitivity in cancer chemotherapy.
    Kuo MT; Fu S; Savaraj N; Chen HH
    Cancer Res; 2012 Sep; 72(18):4616-21. PubMed ID: 22962276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells.
    Holzer AK; Samimi G; Katano K; Naerdemann W; Lin X; Safaei R; Howell SB
    Mol Pharmacol; 2004 Oct; 66(4):817-23. PubMed ID: 15229296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming platinum drug resistance with copper-lowering agents.
    Chen HH; Kuo MT
    Anticancer Res; 2013 Oct; 33(10):4157-61. PubMed ID: 24122978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells.
    Ivy KD; Kaplan JH
    Mol Pharmacol; 2013 Jun; 83(6):1237-46. PubMed ID: 23543413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper transporter 1 in human colorectal cancer cell lines: Effects of endogenous and modified expression on oxaliplatin cytotoxicity.
    Cui H; Zhang AJ; McKeage MJ; Nott LM; Geraghty D; Guven N; Liu JJ
    J Inorg Biochem; 2017 Dec; 177():249-258. PubMed ID: 28551160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
    Larson CA; Adams PL; Jandial DD; Blair BG; Safaei R; Howell SB
    Biochem Pharmacol; 2010 Aug; 80(4):448-54. PubMed ID: 20451502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate and regulation of copper transport by human copper transporter 1 (hCTR1).
    Maryon EB; Molloy SA; Ivy K; Yu H; Kaplan JH
    J Biol Chem; 2013 Jun; 288(25):18035-46. PubMed ID: 23658018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin.
    Larson CA; Adams PL; Blair BG; Safaei R; Howell SB
    Mol Pharmacol; 2010 Sep; 78(3):333-9. PubMed ID: 20519567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordination of platinum therapeutic agents to met-rich motifs of human copper transport protein1.
    Crider SE; Holbrook RJ; Franz KJ
    Metallomics; 2010 Jan; 2(1):74-83. PubMed ID: 21072377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the high-affinity copper transporter (hCtr1) expression by cisplatin and heavy metals.
    Liang ZD; Long Y; Chen HH; Savaraj N; Kuo MT
    J Biol Inorg Chem; 2014 Jan; 19(1):17-27. PubMed ID: 24132751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of hCTR1, the human copper uptake protein.
    Eisses JF; Kaplan JH
    J Biol Chem; 2002 Aug; 277(32):29162-71. PubMed ID: 12034741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.